Small Molecule Encapsulation Service for Targeted Delivery
At Creative Biolabs, we understand that discovering a potent active pharmaceutical ingredient (API) is only half the battle. The true challenge lies in delivering that molecule precisely where it is needed. Our Small Molecule Targeted Delivery Service is engineered to help researchers and pharmaceutical developers dramatically improve the therapeutic index of their drugs, maximizing efficacy while strictly minimizing exposure to healthy tissues.
Request a Free Scientific Consultation
Turning Promising Molecules into Viable Therapeutics
Overcoming the Limitations of Naked Small Molecules
Even the most potent small molecule APIs risk failing in the clinic if they cannot reliably reach their target. Conventional "naked" drugs are constantly hindered by poor aqueous solubility, rapid renal clearance, and indiscriminate biodistribution. These critical flaws dilute the active concentration at the disease site while exposing healthy tissues to severe off-target toxicity, ultimately collapsing the therapeutic window and halting your clinical progression.
The Carrier Solution: Shielding & Stabilizing Your Payload
Advanced nanocarrier delivery systems offer a proven pharmacological rescue strategy. By encapsulating delicate small molecules within highly engineered, biocompatible vehicles (such as liposomes, or polymeric micelles), we fundamentally alter their pharmacokinetic profile. This sophisticated shielding protects your payload from premature enzymatic degradation, drastically enhances solubility, and significantly extends systemic circulation half-life, ensuring the drug survives the journey to the target tissue.
The Precision Navigator: Active Targeting for Unprecedented Specificity
Relying solely on the Enhanced Permeability and Retention (EPR) effect for passive tissue accumulation is no longer sufficient for next-generation therapeutics. Precision medicine demands active homing. By meticulously functionalizing the surface of our nanocarriers with specialized ligands (high-affinity aptamers, specific peptides, or monoclonal antibodies), we engineer active targeting mechanisms. This drives highly specific ligand-receptor binding and forces rapid cellular uptake via receptor-mediated endocytosis, delivering the payload exactly where it is needed—and nowhere else.
Fig. 1 Active and passive targeting in nano-delivery systems for anti-tumor treatment.1
Comprehensive Delivery Engineering Services
Creative Biolabs provides a meticulously engineered, end-to-end service framework tailored specifically for small molecule therapeutics. From the initial blueprint of your nanocarrier to the final functionalized surface, we deliver complete technological solutions to rescue challenging APIs and unlock their full therapeutic potential.
Custom Nanocarrier Formulation & Encapsulation
We provide bespoke formulation design to encapsulate your specific hydrophobic or hydrophilic small molecule, directly overcoming poor aqueous solubility and rapid systemic clearance. Our formulation scientists evaluate your API's physicochemical properties to select, synthesize, and optimize the ideal vehicle architecture, maximizing payload retention and controlling release kinetics.
- Lipid-Based Platforms: Development of highly versatile Liposomes and state-of-the-art Lipid Nanoparticles (LNPs) utilizing active gradient loading technologies.
- Polymer & Inorganic Systems: Synthesis of Polymeric Nanoparticles, Micelles, and Mesoporous Silica Nanoparticles (MSNs) for tunable, sustained release.
- Bio-Inspired Carriers: Isolation and payload-engineering of Exosomes for superior biocompatibility and immune evasion.
- Optimization & Iteration: Rigorous adjustment of lipid/polymer molar ratios to achieve maximum encapsulation efficiency and particle stability.
Workflow
Applications of Targeted Small Molecule Delivery
While our targeted delivery platforms are rooted in advanced biomedical research, the fundamental physics and chemistry of our nanocarriers allow for revolutionary applications across a multitude of industries.
- Agri-Tech & Crop Protection: Targeted delivery of specific pesticides, herbicides, or plant growth regulators directly to essential plant tissues or root systems. This maximizes crop yield while drastically reducing environmental runoff and soil toxicity.
- Cosmeceuticals & Dermatology: Formulating advanced liposomal and polymeric carriers to enhance the deep-skin penetration and sustained release of unstable active ingredients (e.g., antioxidants, anti-aging compounds), targeting specific dermal layers for superior cosmetic efficacy.
- Nutraceuticals & Functional Foods: Encapsulating sensitive vitamins, probiotics, or dietary supplements to protect them against the harsh, acidic gastric environment, thereby significantly enhancing their oral bioavailability and intestinal absorption.
- Veterinary Medicine: Developing targeted therapeutics and next-generation vaccines for companion animals and livestock, improving treatment efficacy, lowering dosage requirements, and increasing animal compliance.
- Industrial & Materials Science: Applying targeted encapsulation technologies for the controlled, stimuli-responsive release of catalysts, anti-corrosion agents, or functional dyes in smart coatings and advanced manufacturing processes.
Why Choose Creative Biolabs?
Creative Biolabs provides industry-leading, highly customizable Targeted Drug Delivery Solutions designed to rescue difficult molecules and maximize their therapeutic index. From cutting-edge carrier engineering to precise ligand functionalization and scalable lyophilization, our modular platforms provide the precise control required for your next breakthrough, regardless of your industry.
Modular Platform Flexibility
Our "mix-and-match" approach allows for nearly infinite combinations of carriers and targeted modules, ensuring a perfectly tailored fit for your unique API.
Unsurpassed Encapsulation Efficiency
Utilizing proprietary loading technologies (such as active gradient loading), we achieve high payload retention even for notoriously difficult hydrophobic molecules.
Seamless Scalability
We engineer formulations with translation in mind, ensuring consistent particle characteristics from milligram pilot studies to larger gram-scale preclinical batches.
Stringent Quality Control
Every batch is backed by comprehensive analytical data, ensuring high batch-to-batch reproducibility and giving you absolute confidence in your in vitro and in vivo results.
Related Services & Products
Related Services
Chemical Synthesis Services
Nucleic Acid Synthesis Services
Related Products
| Product Name | Description | Inquiry |
|---|---|---|
| Clodronate Liposomes (Neutral) | Neutral-charged liposomal clodronate formulations designed for highly efficient, targeted depletion of macrophages in vivo. | |
| Clodronate Liposomes (Anionic) | Negatively charged liposomal formulations optimized for accelerated phagocytosis and enhanced depletion of mononuclear phagocyte system (MPS) cells. | |
| Doxorubicin Liposomes | Highly stable, pre-formulated liposomes encapsulating the chemotherapeutic agent doxorubicin, serving as a reliable standard for oncological drug delivery studies. | |
| LNP Formulation Kit (Universal) | A ready-to-use, comprehensive kit containing proprietary lipid mixes and buffers for the rapid, benchtop assembly of Lipid Nanoparticles. | |
| NGR Peptide | High-purity tumor-homing peptide (Asn-Gly-Arg) targeting CD13/aminopeptidase N, ideal for functionalizing your custom nanocarriers for tumor vascular targeting. |
FAQs
Can your systems target specific subcellular organelles, such as the mitochondria or nucleus?
Yes. We can integrate specialized targeting modules, such as lipophilic cations for mitochondrial targeting or nuclear localization signals (NLS), to dictate subcellular trafficking after endosomal escape.
How do you ensure the stability of the nanocarriers during global shipping?
We highly recommend our custom lyophilization services. By adding specific cryoprotectants, we freeze-dry the formulations into a stable powder, preserving particle integrity, preventing drug leakage, and enabling safe, long-distance logistics.
Do you provide in vivo pharmacokinetic (PK) and pharmacodynamic (PD) testing?
Creative Biolabs focuses purely on formulation, physicochemical characterization, and in vitro release kinetics. We provide you with the optimized, validated delivery system to execute in vivo PK/PD studies in your own facility or with a CRO partner.
What is the minimum amount of API required to initiate a pilot formulation project?
For an initial proof-of-concept and prototype formulation phase, we typically require only 5 to 10 milligrams of your active pharmaceutical ingredient.
Reference
- Chehelgerdi, Mohammad, et al. "Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation." Molecular cancer 22.1 (2023): 169. https://doi.org/10.1186/s12943-023-01865-0. Distributed under Open Access license CC BY 4.0, without modification.
